PathAI logo

DecisionDx-Melanoma

Molecular · Dermatology
31 gene expression profile (28 discriminating, 3 control) for the prediction of metastatic potential in patients with cutaneous melanoma.  Patients are stratified into either low risk Class 1 or high risk Class 2 groups, with sub-classification of A or B within each Class.